Prime Doctor RX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.5/10
Best for: shoppers who want every price tier published up front and can prepay a year for a lower rate
Prime Doctor RX's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Prime Doctor RX is a telehealth brand with a Houston mailing address that sells compounded semaglutide and tirzepatide injections and an oral semaglutide tablet alongside testosterone care, with prescribing by clinicians from OpenLoop Healthcare Partners, PC. It publishes every price tier before intake, but its prices are charged every four weeks rather than monthly. Month to month, semaglutide is $249 and tirzepatide $339 per four-week shipment; the advertised $179 and $269 figures require paying for 52 weeks upfront.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to Prime Doctor RX
Editorial score · methodology
Synergy Rx
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
Editorial score · methodology
RxSpan MD
Best for: knowing which pharmacy fills the vial — it names Belmar Pharmacy
Editorial score · methodology
Prime Doctor RX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $249/mo ($249 billed every 28 days, which adds up to 13 charges a year rather than 12. Prepaid options lower the price per fou...)
- FDA status
- No FDA warning letter on record
How Prime Doctor RX scores
Six columns, each one computed from something Prime Doctor RX has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
3.1/10$339/month is 31% above the register median of $259 for compounded tirzepatide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
6.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on Prime Doctor RX
Last checked September 2026- Re-read the price on file across 3 dose or plan tiers
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.
What signing up with Prime Doctor RX involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1Prime Doctor RX publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3Prime Doctor RX does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- Cheapest standing monthly prices on record: semaglutide $249, tirzepatide $339. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether Prime Doctor RX serves your state cannot be confirmed from its site.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Prime Doctor RX support, as documented
Cancelling Prime Doctor RX
Read from what Prime Doctor RX publishes in its own terms. Where a line says the seller does not publish something, that is the finding — we looked and it is not stated. Terms change; check the seller’s current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Month to month charged every 28 days, or a 12, 24 or 52-week plan paid upfront; cancel at least 72 hours before the next billing date
- Refund policy
- "Refunds may be requested at any time for unused future service periods." A period is generally not refundable once its medication has been ordered.
GLP-1 medications Prime Doctor RX offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
$249 billed every 28 days, which adds up to 13 charges a year rather than 12. Prepaid options lower the price per four-week shipment: 12 weeks for $657 ($219), 24 weeks for $1,194 ($199) and 52 weeks for $2,327 ($179). The $179/mo headline is the 52-week prepay, and each "month" in Prime Doctor RX's pricing is a four-week shipment.
$339 billed every 28 days, or 13 charges a year. Prepaid options: 12 weeks for $927 ($309 per four-week shipment), 24 weeks for $1,734 ($289) and 52 weeks for $3,497 ($269). The $269/mo headline requires the 52-week prepay.
A daily semaglutide tablet at $279 billed every 28 days. Prepaid options: 12 weeks for $777 ($259 per four-week shipment), 24 weeks for $1,434 ($239) and 52 weeks for $2,717 ($209). Prime Doctor RX does not say whether the tablet is compounded or which formulation it is.
Check the price yourself before you pay
Every figure here was read off Prime Doctor RX's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide at $249 a month, within the normal band around this register's $189 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- No FDA warning letter matched this operator when we searched our enforcement register
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Prime Doctor RX charges
Prime Doctor RX charges $249/month. That sits above the middle of the market, which puts the burden on whatever else is in the package.
- Compounded semaglutide — $249/month
- Compounded tirzepatide — $339/month
- Compounded semaglutide — $279/month
The median standing price across the GLP-1 providers we track is about $170/month, so this is a premium, and a premium has to buy something. Check what is bundled before accepting it.
Wellorithm dispenses semaglutide and tirzepatide from $247/month, which makes it the honest comparison to run before committing here.
What Prime Doctor RX dispenses
Prime Doctor RX prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Prime Doctor RX at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.
What we could verify
Prime Doctor RX publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You are optimizing for the twelve-month total rather than the first bill — a flat-rate seller such as Collective will usually win that arithmetic.
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- injections are the thing keeping you from starting
Our read
Prime Doctor RX costs more than the middle of this market, and the oral option is the clearest thing that premium buys. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. Direct Meds is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
Prime Doctor RX's strongest column is the clinical side — which molecules it will prescribe, and how it handles dosing.
Before you pay Prime Doctor RX
Starting at $249 a month. Check today's price, then book the free consultation.
Where Prime Doctor RX is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Found.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider RxSpan MD.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Prime Doctor RX review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of September 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Prime Doctor RX's current pricing
Plans start at $249 a month. The free consultation is where you learn whether you qualify, and what it costs today.